REMINDER: Our user survey closes on Friday, please submit your responses here.
Well, this one certainly gained some traction today. Nice to see some mainstream media coverage with that Guardian article as well.
If we don't see a 7am RNS then I can see this taking another dip around 08:30 before coming back up to test £2 for the long weekend.
Good times for all invested. I'm certainly not in to anywhere near the levels of some on here, but even so I'm already up to "who fancies a month holiday in the Seychelles?" territory with my gains so far. And that's without news of the Affimers confirmed as working and the product ready for market. When that happens... well... how much is a ticket on that Space X rocket? Might have to have a look...
Nasal swab test that takes 60 minutes to return a negative result.
Status - Least Concern.
Just to add to my earlier post, it's also worth mentioning that this agreement realates to the consumer sales.
Medusa 19 has the rights to sell to do B2B sales, but NOT the exclusive rights... which allows AVCT to do whatever B2B deals they see fit - think stadiums, airports, etc.
Bit surprised by the negativity here this morning.
AVCT needs a distributor for this home test kit. So, obvious choices are the likes of Boots, Lloyds Pharmacy, etc. As they're the obvious choices, and this product doesn't have approvals, etc. at this moment, getting a good deal for AVCT with regard to pricing and profits will be difficult.
Instead, major shareholders in AVCT have set up a new company to deal with the distribution. Something they have serious experience in (albeit in a different product line). More importantly, AVCT gets a better profit share deal as the shareholders get two bites of the cherry in that scenario.
Also, those shareholders are so confident in the product getting approval they are setting this all up in advance, so it's ready to go.
I don't see a negative here. Other than people seeing the name of a clothing company on an RNS for distribution of a pharma product. But when you think about, this is much better for AVCT than if that name had been Boots, or Lloyds, or even Amazon.
The question here is "did you buy in based on their 2018 profits?". If so, you would have been invested prior to Dec 18 at sub 20p so even a hefty drop shouldn't phase you too much.
If you bought in based on their Covid work, however, then has anything changed? Certainly not in a negative way, for me. The RNS shows some real positives on that front with investment in RND and partnership revenues.
one of those big swimming floats underwater when you were a kid?
That's what MMs are doing with this right now. They can keep it underwater for a short time, but very soon it has to come shooting back to the surface.
Hold fast, this one has loads more in it.
I don't think 20p within a few weeks is unreasonable.
If they get a successful test regarding the COVID vaccine testing process - pick a number.
I decided to come out of ODX this morning and consoliadte my investments (after skimming some ODX profit) into AVCT. Whist I think ODX has potential to hit 100p, I think it's a riskier share than AVCT and doesn't have the longer term outlook.
So that's that - decision made and all in for AVCT. Let's go to the moon...
"A grand a week just doesn't cut it when you have a name like 'the fox' lol"
it does if you're not referring to the phrase 'cunning as a fox' but more to the fact they eat scraps out of bins.
The swings on this share, made possible by a lot of volume coming from the hype of 000s of % increases in a few months, make this a dream for day traders (nothing wrong with day trades - but it's not what I'm here for).
However, you'll note that before close it spikes right back up again. The reason for that is that regardless of how you play it during the day, no-one wants to be out overnight and miss a 7am RNS.
You are either invested and banking on that next RNS being as big as you think it's going to be, or you're not. But getting scared by these big swings is going to do nothing more than cost you money.
Hold fast, get a bacon sandwich and keep an eye out for an RNS. Once that hits, that's when you've got to start thinking again.
right - barnetpeter I'm probably missing something here. But it seems like you're saying you didn't see the fact that there's NO SPORT affecting Will Hill share price? Then at a 30p low people are, of course, climbing on... because eventually it'll be back up. Have I missed something here?
Aaah - but with the stratospheric success of NCYT and with ODX being so closely linked, it makes sense people are looking here for the next big thing. And there's every chance this is it . I certainly think so or I wouldn't be here.
AVCT is another doing well, but you can buy here for less than half. I'm in both, but when all is said and done I reckon this is the bigger pay. Of course tomorrow or next week or next month that may change. But today, that's where I'm at.
50m market cap - that need to be proven. Time will tell whether that can be smashed.
50p pricing - given the nonsense pricing on other Covid shares I can see ODX doing that purely on hype. Anyone work for Sky News...
No no - I'm invested to the max I'm financially able at the mo. So if this soars to the moon then that's perfect. I was just saying I see a more conservative uptick tomorrow. Still finishing up - but I'm struggling to see the £1 mentioned in the post I was replying to.
All for it if it happens, though.
Yup. Dipped to 56 from a 66 open. Hence why I won't be surprised to see exactly the same from a 68 close today.
Well... I sure hope so.
Personally I can see a bit of tree shaking early on. Maybe even down to 60 to try and find some stop losses. Then a steady rise to just shy of 80 for the weekend close.
But I'd much rather see your scenario!
Let's not forget that a 'big seller' in these types of shares and market can easily be someone coming in for a short term profit skim and happily taking their 10p in 24 hours and moving on to the next.
A lot of new people are getting involved with that share because of the staggering increases week on week recently. It has raised the heads even of people who previously haven't dealt in shares. A lot of the recent volatility will be down to that. Plus peaks and troughs attract traders - which creates bigger peaks and troughs.
If their next RNS shows the kind of profit increases most are expecing then another 25%-40% increase is totally feasible. But the multi bags are done, IMHO.
Over here with AVCT there a better long term upside, I feel. I'm also dabbling in ODX, but with a shorter term outlook - plus I was in there very, very cheap, so that one was a bit of a no brainer. But for AVCT, in early and let it ride. They've got their sh*t together.
Having bought a little too late yesterday I've had a surly day; brightened right at the end!
This coupled with a late rally from another covid-related stock I got in on at mid-teens earlier, means a strong finish.
Onwards and upwards tomorrow.